China, Sept. 30 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy of Vunakizumab in Patients with Moderate-to-Severe Plaque Psoriasis and Obesity: A Single-Center, Prospective Clinical Study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133562

Registration Time: 2026/09/29

Type: Observational study

Primary Sponsor: Shenzhen Second People's Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=345165

Published by HT Digital Content Services with permission from Health Daily Digest....